Directors of health care in WEF reaffirmed
the importance of being acquainted with the great progress achieved
by Jordanian pharmaceutical industry and the importance to reassess
the future strategies of world firms they represent.



In a meeting chaired by His Majesty King Abdulah II, the directors
stressed also that Jordan has entered a new phase of attracting
strategic partners in order to strengthen the local Jordanian
firms.


They pointed out that there are Jordanian firms that enjoy
good reputation in the world market as they export their production
to 63 countries around the world.


His Majesty said that partnership between the private
and public sectors managed to forge pharmaceutical industry that
is capable of competition on the international level. The Kingdom
is seeking to diverse its pharmaceutical industry and to encourage
research and development in this field, he affirmed.


His Majesty expressed interest in attracting world investment
pharmaceutical firms in Jordan in order to help the Jordanian
companies achieve scientific and technical knowledge and innovation,
or contribution to some world pharmaceutical firms production.